Jesse Yenchih Hsu
Overview
Explore the profile of Jesse Yenchih Hsu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
104
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Szperka C, Witzman S, Ostapenko S, Farrar J, Hsu J, Malavolta C, et al.
Headache
. 2023 Nov;
63(10):1359-1371.
PMID: 37975482
Objective: To examine trends in diagnosis of headache and migraine in a large pediatric neurology cohort, and test whether an electronic health record (EHR)-integrated headache questionnaire can increase specificity of...
2.
Tripepi G, DArrigo G, Mallamaci F, London G, Tangri N, Hsu J, et al.
Nephrol Dial Transplant
. 2020 May;
35(12):2203.
PMID: 32437533
No abstract available.
3.
Tripepi G, DArrigo G, Mallamaci F, London G, Tangri N, Hsu J, et al.
Nephrol Dial Transplant
. 2019 Dec;
36(4):665-672.
PMID: 31860093
Background: Left ventricular hypertrophy is causally implicated in the high risk of death and heart failure (HF) in chronic kidney disease (CKD) patients. Whether the left ventricular mass index (LVMI)...
4.
Rahman M, Hsu J, Desai N, Hsu C, Anderson A, Appel L, et al.
Clin J Am Soc Nephrol
. 2018 Feb;
13(4):585-595.
PMID: 29475992
Background And Objectives: Central BP measurements provide noninvasive measurement of aortic BP; our objectives were to examine the association of central and brachial BP measurements with risk of cardiovascular outcomes...
5.
Yang W, Jepson C, Xie D, Roy J, Shou H, Hsu J, et al.
Clin J Am Soc Nephrol
. 2017 Jul;
12(12):2066-2073.
PMID: 28716856
Cardiovascular events, such as hospitalizations because of congestive heart failure, often occur repeatedly in patients with CKD. Many studies focus on analyses of the first occurrence of these events, and...
6.
Hsu J, Roy J, Xie D, Yang W, Shou H, Anderson A, et al.
Clin J Am Soc Nephrol
. 2017 Mar;
12(7):1181-1189.
PMID: 28242844
Survival analysis is commonly used to evaluate factors associated with time to an event of interest ( ESRD, cardiovascular disease, and mortality) among CKD populations. Time to the event of...
7.
George M, Baker J, Hsu J, Wu Q, Xie F, Chen L, et al.
Arthritis Care Res (Hoboken)
. 2017 Jan;
69(12):1845-1854.
PMID: 28129484
Objective: The optimal timing of tumor necrosis factor antagonists before elective surgery is unknown. This study evaluated the association between infliximab timing and serious infection after elective hip or knee...